Open AccessRehabilitation and pharmacotherapy of neuromyelitis optica spectrum disorder: A case report
Author(s) -
Xiaoju Wang,
Peng Xia,
Ting Yang,
Kai Cheng,
Anliang Chen,
Xueping Li
Publication year - 2021
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v9.i16.3951
Subject(s) - medicine , neuromyelitis optica , pharmacotherapy , spectrum disorder , rehabilitation , pediatrics , dermatology , physical therapy , psychiatry , multiple sclerosis
Neuromyelitis optica spectrum disorder (NMOSD) is a demyelinating autoimmune disease that affects the central nervous system. It typically manifests as optic neuritis or extensive longitudinal myelitis, with or without the presence of anti-aquaporin protein 4 autoantibodies (immunoglobulin G).